The Acquired Immunodeficiency Syndrome in Older Persons
West J Med 161:526, Rozance,C.P.&Kizer,K.W., 1994
How Twin Cities Neurologists Treat Ischemic Stroke, Policies and Trends
Arch Neurol 50:1098-1103, Anderson,D.C., 1993
Secondary Prevention in Non-Rheumatic Atrial Fib After TIA or Minor Stroke
European Atrial Fibrillation Trial Study Group, Lancet 342:1255-1262, 1251-1252993., , 1993
Topical Aspirin in Chloroform and the Relief of Pain Due to Herpes Zoster and Postherpetic Neuralgia
Arch Neurol 50:1046-1053, King,R.B., 1993
Clinical Features of Recurrent Embolization in Acute Cardioembolic Stroke
Stroke 24:1681-1685, Yasaka,M.,et al, 1993
Ischemic & Hemorrhagic Stroke in Pts on Oral Anticoagulants After Reconstruct for Chronic Lower Limb Ischemia
Stroke 24:1655-1663, Dawson,I.,et al, 1993
Safety of Anticoagulation After Hemorrhagic Infarction
Neurol 43:1298-1303, Pessin,M.S.,et al, 1993
Coagulation Abnormalities and Cerebral Infarction
JNNP 56:433-439, Greaves,M., 1993
Complications of Therapy for Venous Thromboembolic Disease in Patients with Brain Tumors
Neurol 43:1111-1114, Levin,J.M.,et al, 1993
The Antiphospholipid Syndrome:Ten years On
Lancet 342:341-344, Hughes,G.R.V., 1993
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
NEJM 329:696-702, Eckman,M.H.,et al, 1993
Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993
Deep Cerebral Venous System Thrombosis:Case Report
Neurosurgery 33:911-913, Brown,J.I.M.,et al, 1993
Efficacy of Ticlopidine & Aspirin for Prev of Rev Cerebrovascular Ischemic Events, Ticlopidine Aspirin Study
Stroke 24:1452-1457, Bellavance,A.,et al, 1993
Risk Factors for Complications of Chronic Anticoagulation
Ann Int Med 118:511-520, Fihn,S.D.,et al, 1993
Antithrombotic Therapy in Acute Ischaemic Stroke:An Overviews of the Completed Randomized Trials
JNNP 56:17-25, Sandercock,P.A.G.,et al, 1993
The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993
Laboratory Monitoring of Oral Anticoagulant Therapy:Are We Being Misled?
Neurol 43:468-470, Albers,G.W., 1993
Creutzfeldt-Jakob Disease and Blood Transfusion
lancet 341:205-207, Esmonde,T.F.G.,et al, 1993
Transient Neurologic and Ocular Manifestations in Primary Thrombocythemia
Neurol 43:1107-1110, Michiels,J.J.,et al, 1993
Does Low-Dose ASA Prevent Stroke After Carotid Surgery? A Double-blind, Placebo-controlled Randomized Trial
Stroke 24:1125-1128, Lindblad,B.,et al, 1993
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Acute Compartment Syndromes Resulting from Anticoagulant Treatment
BMJ 305:1474-1475, Hay,S.M.,et al, 1992
Risk FActors for Central Nervous System Manifest of Gastroenteritis-Associated Hemolytic-Uremic Syndrome
Pediatrics 90:616-621, Cimolai,N.,et al, 1992
Failure of High-Dose Heparin to Prevent Recurr Cardioembolic Strokes in Preg Pt with Mech Heart Valve
Neurol 42:2204-2206, Golby,A.J.,et al, 1992
Chronic Myelopathy Associated with Human T-Lymphotropic Virus Type I (HTLV-I)
Ann Int Med 117:933-946, Gessain,A.&Gout,O., 1992
Anticoagulant Treatment as a Risk Factor for Primary Intracerebral Hemorrhage
JNNP 55:1121-1124, Fogelholm,R.,et al, 1992
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Venous Thromboembolism in Stroke:Literature Review and Implications for Clinical Practice
Arch Phys Med Rehabil 73:379-391, Brandstater,M.E.,et al, 1992
Role of Prophyl Anticoag for Direct Current Cardiover in Pts with Atrial Fib, Atrial Flutter
J Am Coll Cardiol 19:851-855, Zeiler,A.,et al, 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992
Cardiogenic Embolism to the Brain
Lancet 339:589-594, Hart,R.G., 1992
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
NEJM 326:605-610, 6371992., Adams,R.,et al, 1992
Reliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy
Arch Int Med 152:278-282, 2571992., Bussey,H.I.,et al, 1992
Cerebral Venous Thrombosis in Behcet's Disease:Clinical Study and Long-Term Follow-Up of 25 Cases
Neurol 42:614-618, Wechsler,B.,et al, 1992
Neurodevelopmental Outcome of Term Infants with Intraventricular Hemorrhage
Am J Dis Child 146:194-197, Jocelyn,L.J.&Casiro,O.G., 1992
Cerebromeningeal Haemophagocytic Lymphohistiocytosis
Lancet 239:104-107, Henter,J.&Elinder,G., 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Neurologic Events after Partial Exchange Transfusion for Priapism in Sickle Cell Disease
J Pediatr 120:882-885, Rackoff,W.R.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Emergency Reversal of Anticoagulation aftr Intracerebral Hemorrhage
Stroke 23:972-977, Fredriksson,K.,et al, 1992
Wilson Disease
Medicine 71:139-164, Brewer,G.J.&Yuzbasiyan-Gurkan,V., 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Antiphospholipid Antibody Syndrome
JAMA 268:1451-1453, Lockshin,M.D., 1992